Patients with resectable tumors had actuarial 3- and 5-year survival rates of 61% and 54%, respectively. Only 1 patient in the palliative group survived beyond 3 years (Figure 1). Two patients in the resection group had distant metastases at the time of diagnosis.
duodenal adenocarcinoma is relatively better (5– year survival, 60%)2 than for patients with ampul-. .. was good, with 3- and 5–year survival rates of 72.9%.
The 5–year survival rate tells you what percent of people live at least 5 years after the cancer is found. Percent means how many out of 100. The 5–year survival .
of All Cancer Deaths 0.2%. Percent Surviving 5 Years. 67.6% 2008-2014. . Modeled trend lines were calculated from the underlying rates using the Joinpoint .
Duodenal adenocarcinoma accounts for more than 50% of all cases of small. . at diagnosis was 49 years and the 5– and 10-year survival rates were 44% and .